×
About 10,516 results
Testosterone - Lab Test
https://labtestsonline.org/tests/testosterone

Jun 4th, 2019 - Why Get Tested? To detect an abnormal testosterone level in males and females; in males, to help diagnose the cause of erectile dysfunction or the inability of your partner to get pregnant (infertility); in females, to help diagnose the cause of masculine physical features (virilization), infertility, or polycystic ovary syndrome (PCOS); in children, to help determine the cause of genitals tha...

Erectile Dysfunction: AUA Guideline
http://www.auanet.org/guidelines/erectile-dysfunction-aua-guideline-(2018)
Arthur L. Burnett

Aug 31st, 2018 - The sexual response cycle is conceptualized as a sequential series of psychophysiological states that usually occur in an orderly progression. These phases were characterized by Masters and Johnson as desire, arousal, orgasm, and resolution.

ACR Appropriateness Criteria Hematospermia
https://www.jacr.org/article/S1546-1440(17)30203-X/fulltext
Hosseinzadeh, K.

Apr 30th, 2017 - Most men with hematospermia or hemospermia (HS) are young (<40 years of age), presenting with transient or episodic HS without other signs or symptoms of disease. The condition is self-limiting in most cases and idiopathic in nature.

Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Maligna...
https://doi.org/10.1001/jama.2015.6604
JAMA Loeb S, Folkvaljon Y et. al.

Jun 23rd, 2015 - The target for the oral erectile dysfunction drugs, phosphodiesterase type 5 (PDE5) inhibitors, is part of a pathway implicated in the development of malignant melanoma. An increased risk of melanoma in sildenafil users was recently reported. To examine the association between use of PDE5 inhibitors and melanoma risk, including data on specific PDE5 inhibitors, number of prescriptions, and mela...

Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178948
JAMA Internal Medicine; Li WQ, Qureshi AA et. al.

Apr 8th, 2014 - The RAS/RAF/mitogen-activated protein kinase and extracellular signal-regulated kinase (ERK) kinase/ERK cascade plays a crucial role in melanoma cell proliferation and survival. Sildenafil citrate (Viagra) is a phosphodiesterase (PDE) 5A inhibitor commonly used for erectile dysfunction. Recent studies have shown that BRAF activation down-regulates PDE5A levels, and low PDE5A expression by BRAF ...

Predictive validity of the Golombok Rust Inventory of Sexual Satisfaction (GRISS) for the presence of sexual dysfunctions within a Dutch urological population
https://www.nature.com/articles/3900966

May 8th, 2003 - The objective of this study was to investigate the predictive validity of the Dutch translation of the Golombok Rust Inventory of Sexual Satisfaction (GRISS) for the presence of clinically relevant sexual dysfunctions and patient's need of help. A total of 57 male urological outpatients (age 50.7±13.2 y; range 27–77 y) completed the GRISS, a 28-item self-report questionnaire assessing sexual dy...

AACE Medical Guidelines for the Clinical Practice for Evaluation and Treatment of Male Sexua...
https://www.aace.com/files/sexdysguid.pdf
AACE Male Sexual Dysfunction Task Force

Dec 31st, 2002 - The purpose of these guidelines is to present a framework for the evaluation, treatment, and follow-up of the patient—indeed, of the couple—who presents with sexual dysfunction. The conventional focus on male erectile dysfunction is incomplete because whenever a man experiences erectile difficulties, his wife or sexual partner suffers as well.

Placebo Responses Among Men With Erectile Dysfunction Enrolled in Phosphodiesterase 5 I...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084170
JAMA Network Open; Stridh A, Pontén M et. al.

Mar 20th, 2020 - Placebo responses in the treatment of erectile dysfunction (ED) are poorly described in the literature to date. To quantify the association of placebo with ED outcomes among men enrolled in placebo-controlled, phosphodiesterase 5 inhibitor (PDE5I) trials. For this systematic review and meta-analysis, a database search was conducted to identify double-blind, placebo-controlled studies using PDE5...

EDEX® (alprostadil for injection)
https://edex.com/hcp.php

edex® (alprostadil for injection) prescription information. ... https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/UCM071436.pdf. Accessed ...

Caverject Impulse® (alprostadil for injection)
https://www.pfizerpro.com/product/caverject-impulse/hcp

Prolonged erection and priapism have occurred in patients receiving CAVERJECT IMPULSE. To minimize the chances of this occurring, titrate CAVERJECT ...

CAVERJECT® IMPULSE (alprostadil) (alprostadil)
https://www.pfizermedicalinformation.com/en-us/caverject-impulse-alprostadil

CAVERJECT IMPULSE (alprostadil) medication page for healthcare professionals to search for scientific information on Pfizer medications. Also find the package insert, announcements, resources, and ways to connect with Pfizer Medical through a variety of channels.

Cialis® (tadalafil)
https://www.cialismd.com/index.html

Cialismd.com is technical in nature and is intended specifically for United States healthcare professionals. If you are not a US healthcare professional, please ...

Viagra® (sildenafil citrate) tablets
https://www1.pfizerpro.com/product/viagra/ed

VIAGRA®(sildenafil citrate) info for HCPs treating patients with ED. Help patients save ... Indication: VIAGRA® (sildenafil citrate) is indicated for the treatment of erectile dysfunction (ED). Prescribing .... For more information, visit www. .... The products discussed herein may have different product labeling in different countries.

TRI-MIX
http://trimixgel.com/erectile-dysfunction-treatment/

Physicians Information - TriMix-gel® ED AlternativeTriMix-gel® ED Alternative

A Clinical Reference Guide on Sexual Devices for Obstetrician-Gynecologists.
https://doi.org/10.1097/AOG.0000000000003262
Obstetrics and Gynecology; Rubin ES, Deshpande NA et. al.

May 28th, 2019 - In the United States, more than half of all women have used a vibrator, nearly one third of women have used a dildo, and more than three quarters of women who have sex with women have used a vibrator. Sexual devices can be used by patients with decreased libido, anorgasmia, conditions inhibiting vaginal penetration, partner erectile dysfunction, and motor or sensory disabilities. Basic knowledg...

The Effect of Shift Work on Urogenital Disease: a Systematic Review.
https://doi.org/10.1007/s11934-018-0815-y
Current Urology Reports; Deng N, Haney NM et. al.

May 28th, 2018 - Non-standard shift work schedules negatively impact the overall health of shift workers, and several studies have shown that shift work, specifically, is detrimental to urogenital health. The aims of this study are to systematically review the literature and determine the effect of shift work on the outcomes of hypogonadism, male infertility, lower urinary tract symptoms, and urogenital cancers...

Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign...
https://doi.org/10.1136/bmj.i4823
BMJ (Clinical Research Ed.); Hagberg KW, Divan HA et. al.

Sep 23rd, 2016 - To estimate the risk of erectile dysfunction in men who used 5-α reductase inhibitors to treat benign prostatic hyperplasia or alopecia. Cohort studies with nested case-control analyses. UK Clinical Practice Research Datalink. Two populations of men free of risk factors for erectile dysfunction and other sexual dysfunction or its treatment: men aged 40 or more with benign prostatic hyperplasia ...

Effect of testosterone treatment on constitutional and sexual symptoms in men with type...
https://doi.org/10.1210/jc.2014-1872
The Journal of Clinical Endocrinology and Metabolism; Gianatti EJ, Dupuis P et. al.

Jun 30th, 2014 - The objective of the study was to assess the effect of T treatment on constitutional and sexual symptoms in men with type 2 diabetes (T2D). This was a randomized double-blind, parallel, placebo-controlled trial. The study was conducted at a tertiary referral center. Men aged 35-70 years with T2D, a hemoglobin A1c less than 8.5%, and a total T level less than 12.0 nmol/L (346 ng/dL) with mild to...

Validity of midday total testosterone levels in older men with erectile dysfunction.
https://doi.org/10.1016/j.juro.2014.01.085
The Journal of Urology; Welliver RC, Wiser HJ et. al.

Feb 12th, 2014 - Based on studies showing the circadian rhythmicity of testosterone the optimal time of day to draw total testosterone in men has classically been reported as between 8 and 11 a.m. However, further studies demonstrated that the testosterone circadian rhythmicity becomes blunted with age. We retrospectively reviewed the charts of 2,569 men who presented with erectile dysfunction for total testost...